Loading clinical trials...
Loading clinical trials...
Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Seung Hwan Lee, M.D., Ph.D.
CONTACT
Lead Sponsor
Addpharma Inc.
NCT02616302 · Gastroesophageal Reflux Disease (GERD)
NCT04506593 · Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), and more
NCT07174882 · Non-Erosive Gastro-Esophageal Reflux Disease, Gastroesophageal Reflux Disease (GERD)
NCT07344935 · Gastroesophageal Reflux Disease (GERD)
NCT07179250 · Incentive Spirometer, Diaphragmatic Breathing, and more
Seoul National University Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions